FK506 treatment in a long-term chronic rejection rat model of small bowel transplantation

Clinical and Investigative Medicine

Volumn 33, Issue 3, 2010, Pages

  Zhu, Yanfei ^a   Wei, Wei ^a   Li, Yousheng ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ANIMAL; ARTICLE; DRUG EFFECT; FISCHER 344 RAT; GRAFT REJECTION; GRAFT SURVIVAL; LEWIS RAT; MALE; RANDOMIZATION; RAT; SMALL INTESTINE; TRANSPLANTATION;

ANIMALS; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; INTESTINE, SMALL; MALE; RANDOM ALLOCATION; RATS; RATS, INBRED F344; RATS, INBRED LEW; TACROLIMUS;

EID: 77953368241     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Braun F, Broering D, Faendrich F. Small intestine transplantation today. Langenbecks Arch Surg 2007;392:227-238
2. Chen Y, Li X, Tian L, et al. Inhibition of sonic hedgehog signaling reduces chronic rejection and prolongs allograft survival in a rat orthotopic small bowel transplantation model. Transplantation 2007;83:1351-1357
3. Flynn B, Park BK, Bond G, et al. Immunosuppressant strategies for intestinal transplantation: a review of a tolerogenic regimen. Prog Transplant 2005;15:60-64
4. Fujishiro J, Tahara K, Inoue S, et al. Immunologic benefits of longer graft in rat allogenic small bowel transplantation. Transplantation 2005;79:190-195
5. Cole O, Rigg K, Shehata M. The effect of different immunosuppressants on alloantigen dependent and independent factors involved in the development of chronic rejection in an animal model. Ann R Coll Surg Engl 2001;83:235-243
6. Wasserberg N, Nunoo-Mensah JW, Ruiz P, Tzakis AG. The effect of immunosuppression on peritoneal adhesions formation after small bowel transplantation in rats. J Surg Res 2007;141:294-298
7. Meyer D, Gasser M, Heemann U, Otto Ch, Ulrichs K, Thiede A. Investigating chronic rejection processes after experimental liver/small bowel transplantation. Transplant Proc 2002;34:2261-2262 (Pubitemid 35299738)
8. Murase N, Ye Q, Nalesnik MA, et al. Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both. Transplantation 2000;70:1632-1641.
9. Guo WH, Tian L, Dallmann MJ, Tam PK. Comparative study of allograft survival of heterotopic and orthotopic small bowel transplantation in rat. Transplantation 2003;75:1895-1897
10. Hillebrands JL, Rozing J. Chronic transplant dysfunction and transplant arteriosclerosis: new insights into underlying mechanisms. Expert Rev Mol Med 2003;5:1-23.
11. Orloff SL, Yin Q, Corless CL, Loomis CB, Rabkin JM, Wagner CR. A rat small bowel transplant model of chronic rejection: histopathologic characteristics. Transplantation 1999;68:766-779
12. Wente MN, Sauer P, Mehrabi A, et al. Review of the clinical experience with a modified release form of tacrolimus [FK506E (MR4)] in transplantation. Clin Transplant 2006;20:80-84
13. Alessiani M, De Ponti F, Fayer F, et al. The influence of surgery, immunosuppressive drugs, and rejection, on graft function after small bowel transplantation: a large-animal study. Transpl Int 2003;16:327-335
14. Ma H, Wang J, Wang J, Li Y, Li J. Fish oil ameliorates the allograft arteriosclerosis of intestine on rats. Pediatr Transplant 2007;11:173-179